Your session is about to expire
← Back to Search
MKET Trial Summary
This trial will test how well ketamine works to reduce OCD symptoms compared to a placebo.
MKET Trial Eligibility Criteria
Inclusion CriteriaYou will be eligible if you check “Yes” for the criteria below
MKET Trial Timeline
Study ObjectivesOutcome measures can provide a clearer picture of what you can expect from a treatment.
Awards & Highlights
MKET Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
To what ailments is Ketamine typically applied?
"Ketamine is a well-known treatment for seizures and epilepsy, but it can also ameliorate the symptoms of amnesia and be employed in certain therapeutic processes."
Are any openings currently available for the trial's participants?
"Unfortunately, no longer are individuals being accepted for this trial. The posting date of June 1st 2016 and last update on May 24th 2022 indicate that recruitment has ceased; however, there are currently 114 active clinical trials involving patients with obsessive-compulsive disorder and 153 studies actively recruiting participants to test Ketamine's efficacy."
How many patients have been enrolled for participation in this experiment?
"Currently, this study is not accepting patients. Initially posted on June 1st 2016 and final edited May 24th 2022, no further submissions are being accepted at the moment. However, there are 114 medical studies recruiting for all individuals with obsessive-compulsive disorder and another 153 clinical trials searching for suitable candidates to test Ketamine's efficacy."
Is there an age limit for enrollees in this investigation?
"The age restrictions for participation in this clinical trial are clear. Participants must be above the legal age of consent and not exceed 65 years old."
Is Ketamine associated with any hazardous effects?
"Ketamine's safety has been established to some degree, so it is given a score of 2. Despite this, there is no evidence that the drug can be effective in treating any conditions yet."
To whom is participation in this trial available?
"In order to be accepted into this clinical trial, candidates must present with obsessive-compulsive disorder and lie within the age range of 18 - 65. The study is currently seeking 120 participants."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How responsive is this trial?
Typically responds via
Most responsive sites:
- Stanford University: < 24 hours
Average response time
- < 1 Day
Share this study with friends